JAC Advance Access published online on September 24, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh430
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Universidade Federal de São Paulo, Unidade de Oncologia Experimental, Departamento de Microbiologia, Imunologia e Parasitologia, 04023-062 São Paulo, Brazil
* To whom correspondence should be addressed. E-mail: lucpol{at}unipr.it.
Objectives: To evaluate whether an engineered synthetic decapeptide (KP) derived from the sequence of a recombinant anti-idiotypic antibody, that represents the internal image of a Pichia anomala killer toxin, could be fungicidal in vitro and therapeutic in vivo against Paracoccidioides brasiliensis and paracoccidioidomycosis (PCM). Methods: Fungicidal activity of KP was assessed in vitro and in vivo by inhibition of colony forming units and by histological examination, 8 days after infection, of organs from mice intravenously injected with a virulent strain of P. brasiliensis (3 x 106 yeast cells) and intraperitoneally treated with KP (3.3 µg/g body weight, three doses), in comparison with control animals equally administered with a scrambled decapeptide (SP). Results: KP but not SP was fungicidal in vitro at 39 ng/multiply-budding yeast cell and less efficiently in its D-isomeric form (0.31 µg/multiply-budding yeast cell). It was also able to markedly reduce the fungal load in organs (liver, lung, spleen) of infected animals. Conclusions: The therapeutic effect observed opens the way for using the antifungal peptide as an alternative control of PCM in association with conventional antifungal drugs.
Revised August 12, 2004
Accepted August 16, 2004
Brief report
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis
2 Dipartimento di Patologia e Medicina di Laboratorio, Sezione di Microbiologia, Università degli Studi di Parma, Viale Gramsci 14, 43100 Parma, Italy
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Conti, W. Magliani, S. Conti, L. Nencioni, R. Sgarbanti, A. T. Palamara, and L. Polonelli Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4331 - 4337. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Fiori, A. Mattana, D. Dessi, S. Conti, W. Magliani, and L. Polonelli In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide J. Antimicrob. Chemother., May 1, 2006; 57(5): 891 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cenci, E. Pericolini, A. Mencacci, S. Conti, W. Magliani, F. Bistoni, L. Polonelli, and A. Vecchiarelli Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide J. Leukoc. Biol., January 1, 2006; 79(1): 40 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Donini, C. Lico, S. Baschieri, S. Conti, W. Magliani, L. Polonelli, and E. Benvenuto Production of an Engineered Killer Peptide in Nicotiana benthamiana by Using a Potato virus X Expression System Appl. Envir. Microbiol., October 1, 2005; 71(10): 6360 - 6367. [Abstract] [Full Text] [PDF] |
||||



